Bacillus cereus endophthalmitis following intravitreous bevacizumab injection

Andrew C. Kopel, Petros E. Carvounis, Eric Holz

Research output: Contribution to journalArticlepeer-review

13 Scopus citations


The first case, of Bacillus cereus endophthalmitis following an intravitreous injection of bevacizumab is described. A 77-year-old man presented to a retina specialist with an active choroidal neovascularization related to age-related macular degeneration for which he received intravitreous bevacizumab (1.25 mg) and post-injection topical gatifloxacin. Eight hours later, the patient woke up with excruciating pain and a decline in vision associated with nausea and vomiting. A vitreous biopsy was performed that revealed B. cereus. Despite intravitreous injections of vancomycin and ceftazidime on day 1 and pars plana vitrectomy with repeat intravitreous injections on day 3, the eye did not recover light perception.

Original languageEnglish (US)
Pages (from-to)153-154
Number of pages2
JournalOphthalmic Surgery Lasers and Imaging
Issue number2
StatePublished - Mar 2008

ASJC Scopus subject areas

  • Surgery
  • Ophthalmology


Dive into the research topics of 'Bacillus cereus endophthalmitis following intravitreous bevacizumab injection'. Together they form a unique fingerprint.

Cite this